SENS ▲ +0.8% - Senseonics Holdings, Inc. $SENS - Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas Senseonics stock rose 0.8% today following the company's announcement of a strategic partnership with Beta Bionics to integrate its Eversense® 365 continuous glucose monitor with the iLet® Bionic Pancreas. The integration would combine Senseonics' long-wear glucose sensing technology with an automated insulin delivery system, potentially expanding the addressable market and clinical applications for both companies' products. 14-SEP-2026 07:01 AM ET